Dynamic Technology Lab Private Ltd Makes New $298,000 Investment in Schrödinger, Inc. (NASDAQ:SDGR)

Dynamic Technology Lab Private Ltd purchased a new stake in shares of Schrödinger, Inc. (NASDAQ:SDGR) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 16,067 shares of the company’s stock, valued at approximately $298,000.

Several other institutional investors and hedge funds have also modified their holdings of the business. Nisa Investment Advisors LLC raised its holdings in Schrödinger by 145.3% during the second quarter. Nisa Investment Advisors LLC now owns 1,413 shares of the company’s stock valued at $27,000 after buying an additional 837 shares in the last quarter. GAMMA Investing LLC increased its holdings in shares of Schrödinger by 49.5% during the 2nd quarter. GAMMA Investing LLC now owns 2,124 shares of the company’s stock valued at $41,000 after acquiring an additional 703 shares during the last quarter. KBC Group NV raised its stake in shares of Schrödinger by 45.4% in the 3rd quarter. KBC Group NV now owns 2,508 shares of the company’s stock valued at $47,000 after acquiring an additional 783 shares in the last quarter. nVerses Capital LLC acquired a new stake in Schrödinger in the 2nd quarter worth approximately $66,000. Finally, Quest Partners LLC boosted its position in Schrödinger by 1,005.6% during the second quarter. Quest Partners LLC now owns 4,555 shares of the company’s stock worth $88,000 after purchasing an additional 4,143 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Transactions at Schrödinger

In related news, insider Margaret Dugan sold 1,531 shares of the firm’s stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $17.78, for a total value of $27,221.18. Following the completion of the transaction, the insider now directly owns 13,469 shares of the company’s stock, valued at $239,478.82. This trade represents a 10.21 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 8.60% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of equities analysts have recently commented on SDGR shares. Morgan Stanley dropped their price target on shares of Schrödinger from $43.00 to $30.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 21st. BMO Capital Markets lifted their target price on shares of Schrödinger from $25.00 to $28.00 and gave the stock an “outperform” rating in a report on Wednesday, November 13th. Three investment analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $32.90.

Schrödinger Price Performance

Shares of Schrödinger stock opened at $22.57 on Monday. The company has a market cap of $1.64 billion, a PE ratio of -9.65 and a beta of 1.50. The firm has a fifty day moving average price of $18.84 and a two-hundred day moving average price of $20.16. Schrödinger, Inc. has a fifty-two week low of $16.67 and a fifty-two week high of $38.00.

Schrödinger (NASDAQ:SDGR) last released its earnings results on Tuesday, November 12th. The company reported ($0.52) earnings per share for the quarter, missing the consensus estimate of ($0.40) by ($0.12). Schrödinger had a negative net margin of 91.84% and a negative return on equity of 35.77%. The company had revenue of $35.30 million during the quarter, compared to the consensus estimate of $41.25 million. During the same quarter in the previous year, the business posted ($0.86) EPS. The firm’s quarterly revenue was down 17.1% on a year-over-year basis. Analysts expect that Schrödinger, Inc. will post -2.29 earnings per share for the current fiscal year.

Schrödinger Company Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.